Zingiberen newsaponin
Zingiberen Newsaponin (Zingiberensis newsaponin) is an orally active type of steroid saponin compound. Zingiberen Newsaponin exerts anti-hepatocellular carcinoma (HCC) effects by inhibiting autophagy and the AKR1C1/JAK2/STAT3 pathway. Zingiberen Newsaponin activates oxidative stress (upregulates ROS and MDA) and mitochondrial pathways, promoting cancer cell apoptosis. Zingiberen Newsaponin alleviates cerebral ischemia-reperfusion (I/R) injury by decreasing the concentration of pro-inflammatory cytokines and inhibits NF-κB. Zingiberen Newsaponin can enhance the activity of SOD, eliminate free radicals and protect nerve cells. Zingiberen Newsaponin induces platelet aggregation[1][2][3].
Product Specifications
CAS Number
91653-50-8
Product Name Alternative
Zingiberensis newsaponin
UNSPSC
12352005
Target
Aldose Reductase; Apoptosis; Autophagy; JAK; NF-κB; Reactive Oxygen Species (ROS) ; SOD; STAT
Type
Natural Products
Related Pathways
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/zingiberen-newsaponin.html
Purity
99.68
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
Molecular Formula
C51H82O22
Molecular Weight
1047.18
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog